Abstract
Introduction: The growing prevalence of diabetes has increased the need for scalable technologies to improve outcomes. My Diabetes My Way (MDMW) is an electronic clinical outcomes among users. MDMW pulls data from a national clinician-facing informatics platform and provides self-management and educational information. This study aims to describe MDMW user demographics through time with respect to the national diabetes population, with a view to addressing potential health inequalities.
Methods: Aggregate data were obtained retrospectively from the MDMW database and annual Scottish Diabetes Survey (SDS) from 2010 to 2020. Variables included diabetes type, sex, age, socio-economic status, ethnicity and glycaemic control. Prevalence of MDMW uptake was calculated using corresponding SDS data as denominators. Comparisons between years and demographic sub-groups were made using chi-squared tests.
Results: Overall uptake of MDMW has steadily increased since implementation. By 2020, of all people with type 1 or type 2 diabetes in Scotland, 13% were fully enrolled to MDMW (39,881/312,326). There was proportionately greater numbers of users in younger, more affluent demographic groups (with a clear social gradient) with better glycaemic control. As uptake has increased through time, so too has the observed gaps between different demographic sub-groups. Conclusion: The large number of MDMW users is encouraging, but remains a minority of people with diabetes in Scotland. There is a risk that innovations like MDMW can widen health inequalities and it is incumbent upon healthcare providers to identify strategies to prevent this.
Methods: Aggregate data were obtained retrospectively from the MDMW database and annual Scottish Diabetes Survey (SDS) from 2010 to 2020. Variables included diabetes type, sex, age, socio-economic status, ethnicity and glycaemic control. Prevalence of MDMW uptake was calculated using corresponding SDS data as denominators. Comparisons between years and demographic sub-groups were made using chi-squared tests.
Results: Overall uptake of MDMW has steadily increased since implementation. By 2020, of all people with type 1 or type 2 diabetes in Scotland, 13% were fully enrolled to MDMW (39,881/312,326). There was proportionately greater numbers of users in younger, more affluent demographic groups (with a clear social gradient) with better glycaemic control. As uptake has increased through time, so too has the observed gaps between different demographic sub-groups. Conclusion: The large number of MDMW users is encouraging, but remains a minority of people with diabetes in Scotland. There is a risk that innovations like MDMW can widen health inequalities and it is incumbent upon healthcare providers to identify strategies to prevent this.
Original language | English |
---|---|
Publication status | Published - Apr 2021 |
Event | Diabetes UK Professional Conference 202 - Online Duration: 19 Apr 2021 → 30 Apr 2021 https://www.diabetes.org.uk/diabetes-uk-professional-conference/conference-information#abstracts |
Conference
Conference | Diabetes UK Professional Conference 202 |
---|---|
Period | 19/04/21 → 30/04/21 |
Internet address |